A High-Risk Patient With COVID-19 Vaccine Hesitancy Successfully Treated With Monoclonal Antibodies Through Two Major Surges

Vaccine hesitancy remains a significant challenge in managing the current pandemic despite highly effective vaccines in the United States. Monoclonal antibodies (mAb) are an essential addition to coronavirus disease 2019 (COVID-19) treatment, along with oral antiviral agents (OAA), for non-hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurjar, Hitesh, Ghazanfar, Haider, Haider, Asim, Hernandez, Nolberto, Jyala, Abhilasha, Chilimuri, Sridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971087/
https://www.ncbi.nlm.nih.gov/pubmed/35371707
http://dx.doi.org/10.7759/cureus.22721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971087/
https://www.ncbi.nlm.nih.gov/pubmed/35371707
http://dx.doi.org/10.7759/cureus.22721

Ejemplares similares